scholarly article | Q13442814 |
P50 | author | Gianluigi Zaza | Q37635234 |
Alessandra Dalla Gassa | Q83226232 | ||
Simona Granata | Q57663671 | ||
P2093 | author name string | Antonio Lupo | |
Paola Tomei | |||
P2860 | cites work | Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses | Q23921756 |
Effect of allopurinol in chronic kidney disease progression and cardiovascular risk | Q24630327 | ||
Mitochondrial calcium signalling and cell death: approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis | Q24649875 | ||
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease | Q25257027 | ||
Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties | Q27863422 | ||
Alpha-lipoic acid as a biological antioxidant | Q27863439 | ||
Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid | Q59078782 | ||
Curcumin maintains cardiac and mitochondrial function in chronic kidney disease | Q61192701 | ||
Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes | Q61512619 | ||
N-acetylcysteine inhibits angiotensin converting enzyme in vivo | Q61794859 | ||
Polyunsaturated fatty acids of the n-3 class in chronic dialysis | Q67598411 | ||
Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: a randomized prospective study | Q68065405 | ||
Results of a long-term administration of omega-3 fatty acids in haemodialysis patients with dyslipoproteinaemia | Q68385261 | ||
Vitamin E inhibits protein kinase c activity | Q68462834 | ||
Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration | Q69610864 | ||
Carnitine deficiency in haemodialysed patients | Q69638583 | ||
Carnitine concentrations in dialysed and undialysed patients with chronic renal insufficiency | Q69712455 | ||
Effects of stilbenes on arachidonate metabolism in leukocytes | Q69945080 | ||
Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression | Q70144052 | ||
Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5ω3) | Q70178686 | ||
Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria | Q70214743 | ||
IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of tocopherols and related compounds. Recommendations 1981 | Q70336356 | ||
Docosahexaenoic acid increases permeability of lipid vesicles and tumor cells | Q70580511 | ||
Perturbation of serum carnitine levels in human adults by chronic renal disease and dialysis therapy | Q70856738 | ||
Effectiveness of green tea tannin on rats with chronic renal failure | Q71229036 | ||
Advanced oxidation protein products as a novel marker of oxidative stress in uremia | Q71324551 | ||
Determination of erythrocyte superoxide dismutase, catalase, glucose-6-phosphate dehydrogenase, reduced glutathione and malonyldialdehyde in uremia | Q71438416 | ||
alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism | Q71785121 | ||
Protein oxidation in hemodialysis and kidney transplantation | Q71807974 | ||
Effects of omega-3 polyunsaturated fatty-acid supplementation on redox status in chronic renal failure patients with dyslipidemia | Q43123261 | ||
Effects of L-carnitine on oxidative stress responses in patients with renal disease | Q43136371 | ||
Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study | Q43147200 | ||
Carvedilol protects against the renal mitochondrial toxicity induced by cisplatin in rats. | Q43272939 | ||
Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease | Q43459082 | ||
Elevated plasma F2-isoprostanes in patients on long-term hemodialysis | Q43586164 | ||
Free radical scavenging by green tea polyphenols | Q43635874 | ||
Effects of quercetin on antioxidant defense in streptozotocin-induced diabetic rats | Q43652384 | ||
Oxidative stress in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and the significant role of vitamin C and E supplementation | Q43734669 | ||
Quercetin prevents glutathione depletion induced by dehydroascorbic acid in rabbit red blood cells | Q43791029 | ||
Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients | Q43797471 | ||
Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes | Q43829978 | ||
Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study | Q43835478 | ||
Effect of Nigella sativa on glucose concentration, lipid peroxidation, anti-oxidant defence system and liver damage in experimentally-induced diabetic rabbits | Q43888681 | ||
Effect of L-carnitine on brain lipid peroxidation and antioxidant enzymes in old rats | Q43928479 | ||
Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients. | Q43964536 | ||
Effect of alpha-lipoic acid on lipid peroxidation and anti-oxidant enzyme activities in diabetic rats | Q43977166 | ||
Resveratrol, a component of wine and grapes, in the prevention of kidney disease | Q44035288 | ||
Curcumin (diferuloylmethane), a singlet oxygen ((1)O(2)) quencher | Q44041028 | ||
Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury | Q44067417 | ||
A highly potent peptide analgesic that protects against ischemia-reperfusion-induced myocardial stunning | Q44068518 | ||
Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients | Q44075419 | ||
Effects of combined quercetin and coenzyme Q(10) treatment on oxidative stress in normal and diabetic rats | Q44145979 | ||
Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation | Q44250309 | ||
Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide | Q44255029 | ||
Early oxidative stress in the diabetic kidney: effect of DL-alpha-lipoic acid | Q44274282 | ||
Effect of n-3 fatty acids from fish oil on hemostasis, blood pressure, and lipid profile of dialysis patients | Q44284747 | ||
The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial | Q44324616 | ||
Phase I study of oral bioflavonoids in cadaveric renal transplant recipients: effects on delayed graft function and calcineurin inhibitor toxicities | Q44366795 | ||
Protective effect of N-acetylcysteine on renal ischemia/reperfusion injury in the rat. | Q44373073 | ||
5-Lipoxygenase-mediated mitochondrial damage and apoptosis of mononuclear cells in ESRD patients | Q44402747 | ||
Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. | Q44438488 | ||
In vitro peroxynitrite scavenging activity of diarylheptanoids from Curcuma longa | Q44442246 | ||
alpha-Lipoic acid: a metabolic antioxidant which regulates NF-kappa B signal transduction and protects against oxidative injury | Q44444269 | ||
Thymoquinone is a potent superoxide anion scavenger | Q44484105 | ||
A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study | Q44487840 | ||
Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats | Q44495010 | ||
N-acetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients--a pilot study. | Q44496423 | ||
Complex I and cytochrome c are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria | Q44502175 | ||
N-acetylcysteine improves nitric oxide and alpha-adrenergic pathways in mesenteric beds of spontaneously hypertensive rats | Q44506114 | ||
Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial | Q44515187 | ||
Uric acid and the state of the intrarenal renin-angiotensin system in humans | Q44598792 | ||
The effect of vitamin E supplementation on antioxidant enzyme activities and lipid peroxidation levels in hemodialysis patients | Q44668759 | ||
Green tea inhibits human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1alpha activation | Q44727254 | ||
(-)-Epicatechin 3-O-gallate ameliorates the damages related to peroxynitrite production by mechanisms distinct from those of other free radical inhibitors | Q44789810 | ||
Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats | Q44821844 | ||
L-carnitine ameliorates oxidative damage due to chronic renal failure in rats | Q44835402 | ||
Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury | Q44922430 | ||
Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro | Q44926018 | ||
Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation | Q44945294 | ||
Curcumin and enalapril ameliorate renal failure by antagonizing inflammation in 5/6 nephrectomized rats: role of phospholipase and cyclooxygenase | Q44970228 | ||
Failure of N-acetylcysteine to reduce low-density lipoprotein oxidizability in healthy subjects | Q45027328 | ||
Inhibition of transforming growth factor beta 1 induction by dietary vitamin E in unilateral ureteral obstruction in rats | Q45105846 | ||
Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling | Q45121583 | ||
Carvedilol attenuates ischemia-reperfusion-induced oxidative renal injury in rats | Q45153273 | ||
Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress | Q45165519 | ||
Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats | Q45195077 | ||
Inflammation and carnitine in hemodialysis patients | Q45222182 | ||
Insulin resistance in patients with chronic kidney disease. | Q45247208 | ||
Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients | Q46098839 | ||
Interactions between ubiquinones and vitamins in membranes and cells | Q46122083 | ||
The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study | Q46192679 | ||
In vitro toxicological properties of thymoquinone | Q46245842 | ||
Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality | Q28292632 | ||
Curcumin prevents adriamycin nephrotoxicity in rats | Q28343966 | ||
The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats | Q28376160 | ||
Low levels of dehydroascorbic acid in uraemic serum and the partial correction of dehydroascorbic acid deficiency by haemodialysis | Q28378233 | ||
The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin | Q28387020 | ||
Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin | Q28477422 | ||
A water soluble CoQ10 formulation improves intracellular distribution and promotes mitochondrial respiration in cultured cells | Q28481504 | ||
MitoQ blunts mitochondrial and renal damage during cold preservation of porcine kidneys | Q28484886 | ||
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients | Q28534658 | ||
Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney | Q28570995 | ||
NADPH oxidase: an update | Q28611494 | ||
Selective targeting of an antioxidant to mitochondria | Q30581066 | ||
Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. | Q30925904 | ||
The effect of Nigella sativa oil on gentamicin nephrotoxicity in rats | Q31063861 | ||
Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties | Q31621261 | ||
Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment | Q31832598 | ||
Vitamin E, lipid profile, and peroxidation in hemodialysis patients. | Q31905827 | ||
Protection by ascorbic acid from denaturation and release of cytochrome c, alteration of mitochondrial membrane potential and activation of multiple caspases induced by H(2)O(2), in human leukemia cells | Q33183601 | ||
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease | Q33495688 | ||
d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties | Q33654586 | ||
AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol | Q33688533 | ||
Imbalance of oxidants and antioxidants in haemodialysis patients | Q33712868 | ||
Sirt1 activation protects the mouse renal medulla from oxidative injury | Q33755433 | ||
Drug delivery to mitochondria: the key to mitochondrial medicine | Q33853014 | ||
Antioxidant properties of flavonol glycosides from green beans | Q33874907 | ||
Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). | Q33947741 | ||
Therapeutic targeting of mitochondrial superoxide in hypertension | Q33981734 | ||
Beneficial effects of green tea--a review. | Q33994592 | ||
Is alpha-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity. | Q34011073 | ||
Uncoupling proteins 2 and 3 are highly active H(+) transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone) | Q34080930 | ||
Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3 | Q34086829 | ||
Coenzyme Q10 contents in foods and fortification strategies. | Q34105251 | ||
Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man. | Q34190427 | ||
Pharmacological and toxicological properties of Nigella sativa | Q34193800 | ||
Exploring metabolic dysfunction in chronic kidney disease | Q36123347 | ||
Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. | Q36269184 | ||
Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. | Q36380401 | ||
Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes | Q36386150 | ||
Conjugated linoleic acid or omega 3 fatty acids increase mitochondrial biosynthesis and metabolism in skeletal muscle cells | Q36448426 | ||
Therapeutic roles of curcumin: lessons learned from clinical trials | Q36502400 | ||
Biosynthesis of heme in mammals | Q36535259 | ||
Targeting antioxidants to mitochondria by conjugation to lipophilic cations. | Q36609730 | ||
Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? | Q36620178 | ||
Human epicardial adipose tissue: a review | Q36836168 | ||
Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis | Q36847322 | ||
The effects and mechanisms of mitochondrial nutrient alpha-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: an overview | Q36867029 | ||
The effect of vitamin E-bonded polysulfone membrane dialyzer on a new oxidative lipid marker | Q36935026 | ||
Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. | Q36936364 | ||
Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. | Q36956768 | ||
A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction | Q36977395 | ||
Direct and indirect antioxidant properties of inducers of cytoprotective proteins | Q37104827 | ||
Curcumin and the cellular stress response in free radical-related diseases. | Q37268964 | ||
α-Lipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway | Q37295751 | ||
Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. | Q37335062 | ||
Cellular signaling perturbation by natural products | Q37373545 | ||
Effect of different stages of chronic kidney disease and renal replacement therapies on oxidant-antioxidant balance in uremic patients | Q37422416 | ||
Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals | Q37438177 | ||
Grapes, wines, resveratrol, and heart health | Q37601230 | ||
Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysis | Q37603998 | ||
Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial | Q37604744 | ||
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. | Q37646842 | ||
Inactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria-targeted antioxidant mitigates injury | Q37655972 | ||
Insulin resistance and protein energy metabolism in patients with advanced chronic kidney disease | Q37779350 | ||
In search of novel highly active mitochondria-targeted antioxidants: thymoquinone and its cationic derivatives. | Q38105814 | ||
Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits | Q38147790 | ||
Mitochondrial dysfunction in the pathophysiology of renal diseases | Q38168664 | ||
Human epicardial adipose tissue is a source of inflammatory mediators | Q34272633 | ||
Prevention of diabetic nephropathy in Ins2(+/)⁻(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. | Q34277437 | ||
L-carnitine in dialysis patients | Q34291815 | ||
Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial | Q34292912 | ||
Biochemical, physiological and medical aspects of ubiquinone function | Q34298940 | ||
Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. | Q34307430 | ||
The chemistry and biological activities of N-acetylcysteine | Q34341263 | ||
L-Carnitine supplementation for adults with end-stage kidney disease requiring maintenance hemodialysis: a systematic review and meta-analysis | Q34394337 | ||
Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity | Q34463221 | ||
Docosahexaenoic acid enhances the antioxidant response of human fibroblasts by upregulating gamma-glutamyl-cysteinyl ligase and glutathione reductase | Q34488939 | ||
Uremic toxicity: present state of the art. | Q34510518 | ||
T channels and steroid biosynthesis: in search of a link with mitochondria | Q34535662 | ||
Pharmacokinetics of L-carnitine | Q34536074 | ||
Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review. | Q34539748 | ||
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. | Q34552323 | ||
Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism | Q34553283 | ||
Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury | Q34561378 | ||
Effect of curcumin on the induction of glutathione S-transferases and NADP(H):quinone oxidoreductase and its possible mechanism of action | Q34581128 | ||
Curcumin: from ancient medicine to current clinical trials. | Q34589151 | ||
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases | Q34594807 | ||
Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets | Q34602448 | ||
Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance | Q34604505 | ||
Renal preservation effect of ubiquinol, the reduced form of coenzyme Q10 | Q34623915 | ||
Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. | Q34629660 | ||
Mechanism of adriamycin cardiotoxicity: evidence for oxidative stress | Q34714578 | ||
n-3 fatty acids and serum lipoproteins: human studies | Q34739799 | ||
Fish oil for prevention of sudden death in hemodialysis patients? | Q34752039 | ||
Apoptotic pathways: the roads to ruin | Q34753431 | ||
Green tea polyphenols stimulate mitochondrial biogenesis and improve renal function after chronic cyclosporin a treatment in rats | Q34766031 | ||
Immunological basis of inflammation in dialysis | Q34766523 | ||
Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease | Q34806160 | ||
Delivery of bioactive molecules to mitochondria in vivo. | Q34983135 | ||
Tat-mediated delivery of heterologous proteins into cells | Q34991904 | ||
A modern approach to the treatment of mitochondrial disease | Q35011397 | ||
Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury | Q35012392 | ||
Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients | Q35022243 | ||
Cross-over study of influence of oral vitamin C supplementation on inflammatory status in maintenance hemodialysis patients | Q35042578 | ||
Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions | Q35066981 | ||
Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference | Q35094875 | ||
Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease | Q35108913 | ||
Allopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study | Q35121532 | ||
Dialysis-related carnitine disorder and levocarnitine pharmacology | Q35128999 | ||
Vitamin C in chronic kidney disease and hemodialysis patients | Q35138405 | ||
Lipoic acid: a multifunctional antioxidant | Q35191185 | ||
NLRP3 inflammasome activation in dialyzed chronic kidney disease patients | Q35208558 | ||
Epigallocatechin-3-gallate attenuates unilateral ureteral obstruction-induced renal interstitial fibrosis in mice | Q35217895 | ||
Renal oxidative stress induced by long-term hyperuricemia alters mitochondrial function and maintains systemic hypertension. | Q35414340 | ||
Cell-permeable, mitochondrial-targeted, peptide antioxidants | Q35594854 | ||
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy | Q35640707 | ||
Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension | Q35748416 | ||
Pharmacology of carvedilol | Q35773804 | ||
Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury | Q35889075 | ||
Oxidative stress in uremia: nature, mechanisms, and potential consequences | Q35921174 | ||
Heme oxygenase-1 as a protective gene. | Q35925406 | ||
The mitochondria-targeted antioxidant mitoquinone protects against cold storage injury of renal tubular cells and rat kidneys. | Q36057168 | ||
Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology. | Q36088221 | ||
Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats | Q82299221 | ||
Estimation of oxidative stress markers in chronic kidney disease | Q82433186 | ||
Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis | Q82714205 | ||
The effects of fish oil supplementation on markers of inflammation in chronic kidney disease patients | Q83346598 | ||
Nutritional compounds influence tissue factor expression and inflammation of chronic kidney disease patients in vitro | Q83374012 | ||
Protective effects of thymoquinone on vancomycin-induced nephrotoxicity in rats | Q83408814 | ||
Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty | Q83463194 | ||
Omega-3 fatty acids supplementation does not affect serum lipids in chronic hemodialysis patients | Q83721590 | ||
N-acetylcysteine may improve residual renal function in hemodialysis patients: a pilot study | Q84025711 | ||
Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity | Q84163908 | ||
Effect of captopril treatment on recuperation from ischemia/reperfusion-induced acute renal injury | Q84380794 | ||
Curcumin and vitamin E modulate hepatic antioxidant gene expression in PTU-induced hypothyroid rats | Q84459135 | ||
Current place of beta-blockers in the treatment of hypertension | Q84564330 | ||
N-acetylcysteine improves residual renal function in peritoneal dialysis patients: a pilot study | Q84732572 | ||
Effects of alpha-lipoic acid supplementation on inflammation, oxidative stress, and serum lipid profile levels in patients with end-stage renal disease on hemodialysis | Q84931385 | ||
Ameliorative effects of curcumin against renal injuries mediated by inducible nitric oxide synthase and nuclear factor kappa B during gentamicin-induced toxicity in Wistar rats | Q84957038 | ||
N-acethyl-cysteine reduces the occurrence of contrast-induced acute kidney injury in patients with renal dysfunction: a single-center randomized controlled trial | Q85397603 | ||
L-carnitine supplementation in dialysis: treatment in quest of disease | Q85508686 | ||
Serum coenzyme Q10 levels are associated with coronary flow reserve in hemodialysis patients | Q85549628 | ||
Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis | Q87326349 | ||
The effects of allopurinol on metabolic acidosis and endothelial functions in chronic kidney disease patients | Q87482706 | ||
Epicardial fat tissue thickness is correlated with diminished levels of co-enzyme Q10, a major antioxidant molecule among hemodialysis patients | Q87995087 | ||
Notice | Q93609107 | ||
Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats | Q95721006 | ||
Carotid remodeling of hypertensive subjects and polymorphism of the angiotensin-converting enzyme gene | Q95825461 | ||
Effects of stilbenes on arachidonate metabolism in leukocytes | Q105033274 | ||
Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution? | Q38262965 | ||
Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase | Q38283016 | ||
Role of protein kinase C delta in curcumin-induced antioxidant response element-mediated gene expression in human monocytes. | Q38316154 | ||
Mitochondrial dysfunction confers albumin-induced NLRP3 inflammasome activation and renal tubular injury | Q38908219 | ||
Resveratrol prevents high glucose-induced epithelial-mesenchymal transition in renal tubular epithelial cells by inhibiting NADPH oxidase/ROS/ERK pathway | Q38925447 | ||
A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease | Q39110459 | ||
Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury | Q39339574 | ||
Effects of acute and chronic L-arginine treatment in experimental hyperuricemia | Q39341867 | ||
High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol. | Q39412268 | ||
Carnitine metabolism in chronic renal failure | Q39691274 | ||
L-carnitine attenuates oxidant injury in HK-2 cells via ROS-mitochondria pathway | Q39749317 | ||
Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells | Q39993950 | ||
Antioxidative and anti-inflammatory actions of docosahexaenoic acid and eicosapentaenoic acid in renal epithelial cells and macrophages | Q40103100 | ||
Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. | Q40116114 | ||
The syndrome of systemic carnitine deficiency: Clinical, morphologic, biochemical, and pathophysiologic features | Q40304719 | ||
Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines | Q40363556 | ||
Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines | Q40374129 | ||
Flavonoids differentially modulate nitric oxide production pathways in lipopolysaccharide-activated RAW264.7 cells | Q40434732 | ||
Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. | Q40514487 | ||
Protection against renal ischemia-reperfusion injury in vivo by the mitochondria targeted antioxidant MitoQ | Q40544872 | ||
Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. | Q40552558 | ||
The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. | Q40576530 | ||
Role of bioincompatibility in dialysis morbidity and mortality | Q40646782 | ||
Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells | Q40665840 | ||
Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage | Q40666301 | ||
Atherogenesis and cardiac death: are they related to dialysis procedure and biocompatibility? | Q40691984 | ||
NF-kappa B inhibition by omega -3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription | Q40696197 | ||
Novel cell-penetrating peptide targeting mitochondria. | Q40714243 | ||
Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. | Q40781318 | ||
Stability and structure of binary and ternary complexes of α-lipoate and lipoate derivatives with Mn2+, Cu2+, and Zn2+ in solution | Q40896634 | ||
Molecular basis of alpha-tocopherol control of smooth muscle cell proliferation | Q41055602 | ||
Basic research in antioxidant inhibition of steps in atherogenesis | Q41246398 | ||
In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions | Q41381303 | ||
Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors | Q41385804 | ||
Synergy of mycophenolate mofetil and bioflavonoids in prevention of immune and ischemic injury | Q41741777 | ||
Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction | Q41752424 | ||
The effects of ascorbic acid on the intracellular metabolism of iron and ferritin | Q41914893 | ||
Interactions between ascorbyl free radical and coenzyme Q at the plasma membrane | Q41918144 | ||
The Relationship between Epicardial Adipose Tissue and Coronary Artery Calcification in Peritoneal Dialysis Patients | Q42262609 | ||
Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus | Q42268911 | ||
Epigallocatechin-3-gallate reduces airway inflammation in mice through binding to proinflammatory chemokines and inhibiting inflammatory cell recruitment | Q42280341 | ||
Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5/6 nephrectomized rats | Q42285179 | ||
Ascorbate recycling in human erythrocytes: role of GSH in reducing dehydroascorbate | Q42552688 | ||
Effect of curcumin on cisplatin- and oxaliplatin-induced oxidative stress in human embryonic kidney (HEK) 293 cells | Q42740245 | ||
Hemodialysis Alters Lipid Profiles, Total Antioxidant Capacity, and Vitamins A, E, and C Concentrations in Humans | Q42796945 | ||
Carvedilol protects against cisplatin-induced oxidative stress, redox state unbalance and apoptosis in rat kidney mitochondria. | Q42838598 | ||
Amelioration of gentamicin nephrotoxicity by green tea extract in uninephrectomized rats as a model of progressive renal failure | Q42855719 | ||
Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients | Q42878436 | ||
The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients | Q42997190 | ||
The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study. | Q43004145 | ||
N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration | Q43012450 | ||
Effect of N-acetylcysteine on serum creatinine and kidney function: results of a randomized controlled trial. | Q43028857 | ||
Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction | Q43058797 | ||
Immunosuppressive effect of quercetin on dendritic cell activation and function | Q43059672 | ||
Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress | Q43108544 | ||
Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. | Q46253330 | ||
Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents | Q46347363 | ||
L-carnitine infusions may suppress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients. | Q46435770 | ||
Hypoxia-reoxygenation-induced mitochondrial damage and apoptosis in human endothelial cells are inhibited by vitamin C. | Q46458401 | ||
Decreasing the oxidant stress from paraquat in isolated perfused rat lung using captopril and niacin | Q46459386 | ||
Antioxidant and radical scavenging properties of curcumin | Q46545266 | ||
Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients | Q46570325 | ||
Inhibition of NF-kappa B activation by vitamin E derivatives | Q46571552 | ||
Contemporary use and effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention | Q46593713 | ||
The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study | Q46626955 | ||
Assessment of plasma antioxidant status in hemodialysis patients. | Q46665613 | ||
Effect of quercetin on metallothionein, nitric oxide synthases and cyclooxygenase-2 expression on experimental chronic cadmium nephrotoxicity in rats | Q46754701 | ||
Antioxidant and antiradical activities of L-carnitine | Q46777344 | ||
Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system | Q46809905 | ||
Increased phagocytic nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide production in patients with early chronic kidney disease. | Q46841643 | ||
Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: a randomized placebo controlled trial | Q46863636 | ||
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level | Q46867932 | ||
Resveratrol attenuates cisplatin-induced nephrotoxicity in rats. | Q46890612 | ||
Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction | Q46979246 | ||
N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity | Q46987172 | ||
Plasma metabolites of quercetin and their antioxidant properties | Q47746869 | ||
Cytokines and bioincompatibility | Q47776372 | ||
Curcumin ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in mice | Q48106669 | ||
The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial | Q48331973 | ||
A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36. | Q48333608 | ||
N-acetylcysteine for the prevention of contrast-induced nephropathy in the emergency department. | Q48601036 | ||
Epigallocatechin-3-Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF-κB and Nrf2/HO-1 Signalling Pathway Regulation. | Q50282637 | ||
Therapeutic potential of EGCG on acute renal damage in a rat model of obstructive nephropathy. | Q50484759 | ||
A mitochondria-targeted macrocyclic Mn(II) superoxide dismutase mimetic. | Q50488654 | ||
Evaluation of renal protective effects of the green-tea (EGCG) and red grape resveratrol: role of oxidative stress and inflammatory cytokines. | Q50523725 | ||
Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis. | Q50538525 | ||
A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial. | Q50548448 | ||
Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. | Q50723695 | ||
Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. | Q51052485 | ||
Vitamin E regulates mitochondrial hydrogen peroxide generation. | Q52536406 | ||
Decrease of serum paraoxonase activity in chronic renal failure. | Q52566475 | ||
Quercetin ameliorates methotrexate-induced renal damage, apoptosis and oxidative stress in rats. | Q52663295 | ||
Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients? | Q52992482 | ||
Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway. | Q53077318 | ||
Vitamin E down-modulates mitogen-activated protein kinases, nuclear factor-kappaB and inflammatory responses in lung epithelial cells. | Q53577297 | ||
Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: a pilot study. | Q53579779 | ||
Mitochondrial dysfunction accounts for aldosterone-induced epithelial-to-mesenchymal transition of renal proximal tubular epithelial cells. | Q54309282 | ||
Mitochondrial Targeting with Antioxidant Peptide SS-31 Prevents Mitochondrial Depolarization, Reduces Islet Cell Apoptosis, Increases Islet Cell Yield, and Improves Posttransplantation Function | Q55982431 | ||
Mitochondria-Targeted Antioxidant MitoQ 10 Improves Endothelial Function and Attenuates Cardiac Hypertrophy | Q56970686 | ||
Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure | Q57996800 | ||
Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes | Q58329660 | ||
Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations | Q58865109 | ||
Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes | Q71942060 | ||
Regulation of neutrophil superoxide generation by alpha-tocopherol in human peripheral and umbilical-cord blood | Q71954016 | ||
The correlation between active oxygens scavenging and antioxidative effects of flavonoids | Q72150971 | ||
Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis | Q72184736 | ||
Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages | Q72256241 | ||
Serum coenzyme Q10 in uremic patients on chronic hemodialysis | Q72320048 | ||
Effects of fish oil rich in eicosapentaenoic acid on serum lipid in hyperlipidemic hemodialysis patients | Q72394316 | ||
A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats | Q73066471 | ||
Lipid-lowering effect of polyunsaturated fatty acids in hemodialysis patients | Q73168666 | ||
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial | Q73176018 | ||
Evidence for role of transforming growth factor-beta in RRR-alpha-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells | Q73219085 | ||
Nitric oxide scavenging by curcuminoids | Q73272444 | ||
Enalapril and captopril enhance antioxidant defenses in mouse tissues | Q73281806 | ||
The influence of cyclosporin on lipid peroxidation and superoxide dismutase in adriamycin nephropathy in rats | Q73288247 | ||
Plasma protein thiol oxidation and carbonyl formation in chronic renal failure | Q73293282 | ||
Radical scavenging activity of tea catechins and their related compounds | Q73300163 | ||
Effect of docosahexaenoic acid on mouse mitochondrial membrane properties | Q73379693 | ||
High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.). | Q73501506 | ||
Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation | Q73515814 | ||
Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells | Q73589663 | ||
Correlation between plasma carnitine, muscle carnitine and glycogen levels in maintenance hemodialysis patients | Q73605305 | ||
Carvedilol: a beta blocker with antioxidant property protects against gentamicin-induced nephrotoxicity in rats | Q73962543 | ||
Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy | Q74084029 | ||
Antioxidant activity of Nigella sativa essential oil | Q74108641 | ||
RRR-alpha-tocopherol regulation of gene transcription in response to the cell oxidant status | Q74478533 | ||
Plasma glutathione peroxidase activity is reduced in haemodialysis patients | Q74526054 | ||
Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients | Q77108090 | ||
Prophylaxis of hemodialysis graft thrombosis with fish oil: double-blind, randomized, prospective trial | Q77374146 | ||
Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice | Q77419261 | ||
Effect of plant flavonoids on immune and inflammatory cell function | Q77440716 | ||
Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension | Q77459905 | ||
alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation | Q77604560 | ||
Salvage of cyclosporine A-induced oxidative stress and renal dysfunction by carvedilol | Q78354457 | ||
The enzymic formation of haem by the incorporation of iron into protoporphyrin; importance of ascorbic acid, ergothioneine and glutathione | Q78641896 | ||
Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats | Q79142160 | ||
Oxidative stress is progressively enhanced with advancing stages of CKD | Q79293648 | ||
Effects of L-carnitine infusions on inflammatory and nutritional markers in haemodialysis patients | Q79967377 | ||
Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis | Q80076165 | ||
Potent mitochondria-targeted peptides reduce myocardial infarction in rats | Q80147610 | ||
Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats | Q80170194 | ||
Comparative effects of curcuminoids on endothelial heme oxygenase-1 expression: ortho-methoxy groups are essential to enhance heme oxygenase activity and protection | Q80213574 | ||
The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure | Q80515435 | ||
The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts | Q81039999 | ||
Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury | Q81901994 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chronic renal insufficiency | Q736715 |
nutrition | Q2138622 | ||
mitochondrion | Q39572 | ||
P304 | page(s) | 49 | |
P577 | publication date | 2015-11-25 | |
P1433 | published in | Nutrition and Metabolism | Q15752980 |
P1476 | title | Mitochondria: a new therapeutic target in chronic kidney disease | |
P478 | volume | 12 |
Q95841103 | "Mitochondrial Toolbox" - A Review of Online Resources to Explore Mitochondrial Genomics |
Q52589096 | Ameliorative Effect of Coenzyme Q10 and/or Candesartan on Carboplatin-Induced Nephrotoxicity: Roles of Apoptosis, Transforming Growth Factor-Β1, Nuclear Factor Kappa-B And The Nrf2/HO-1 Pathway |
Q92874299 | Association of Low Serum l-Carnitine Levels with Peripheral Arterial Stiffness in Patients Who Undergo Kidney Transplantation |
Q52589595 | Autophagy inhibition attenuates hyperoxaluria-induced renal tubular oxidative injury and calcium oxalate crystal depositions in the rat kidney. |
Q103029049 | Changes of protein levels in human urine reflect the dysregulation of signaling pathways of chronic kidney disease and its complications |
Q90109175 | Comparative study on isolation and mitochondrial function of adult mouse and rat cardiomyocytes |
Q28854321 | Curcumin prevents mitochondrial dynamics disturbances in early 5/6 nephrectomy: Relation to oxidative stress and mitochondrial bioenergetics |
Q42292920 | Dahuang Fuzi Decoction Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in Chronic Aristolochic Acid Nephropathy. |
Q45071365 | Dynamin-Related Protein 1 Deficiency Promotes Recovery from AKI. |
Q92438376 | Efficacy of a mitochondrion-targeting agent for reducing the level of urinary protein in rats with puromycin aminonucleoside-induced minimal-change nephrotic syndrome |
Q90366970 | End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression |
Q99608572 | Food as medicine: targeting the uraemic phenotype in chronic kidney disease |
Q64969525 | Genetic Susceptibility to Chronic Kidney Disease - Some More Pieces for the Heritability Puzzle. |
Q90563997 | Metabolic requirements of the nephron |
Q47733127 | Metabolomics reveal mitochondrial and fatty acid metabolism disorders that contribute to the development of DKD in T2DM patients |
Q48026176 | Mitochondria Damage and Kidney Disease |
Q39429579 | Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease |
Q26739475 | New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease |
Q64227280 | Oxidative Balance and Inflammation in Hemodialysis Patients: Biomarkers of Cardiovascular Risk? |
Q90632991 | Platelet Mitochondrial Respiration, Endogenous Coenzyme Q10 and Oxidative Stress in Patients with Chronic Kidney Disease |
Q57806981 | Protective Role of Histidine Supplementation Against Oxidative Stress Damage in the Management of Anemia of Chronic Kidney Disease |
Q46448878 | Quercetin attenuates vascular calcification by inhibiting oxidative stress and mitochondrial fission |
Q93173139 | Sestrin‑2 regulates podocyte mitochondrial dysfunction and apoptosis under high‑glucose conditions via AMPK |
Q37564931 | The Leaf of Diospyros kaki Thumb Ameliorates Renal Oxidative Damage in Mice with Type 2 Diabetes |
Q47130640 | The NLPR3 inflammasome and obesity-related kidney disease. |
Q39056509 | The metabolic syndrome and chronic kidney disease |
Q39604490 | The nephroprotection exerted by curcumin in maleate-induced renal damage is associated with decreased mitochondrial fission and autophagy. |
Q26740125 | Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease |
Q37453444 | Upregulation of Oxidative Stress Related Genes in a Chronic Kidney Disease Attributed to Specific Geographical Locations of Sri Lanka. |
Search more.